SCHEMBL13601375

SCHEMBL13601375

CC1CCN(CC(=O)OCCCN(C)C)CC1

nearest known ligand 0.40

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HRH3 Q9Y5N1 5/20 0.39
KMT2A Q03164 2/20 0.38
HPGD P15428 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
UTS2R Q9UKP6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601372 0.91 CHRM2 (0.41) NPC1SMN1; SMN2ALDH1A1HRH3KMT2A
SCHEMBL13601418 0.86 POLB (0.46) NPC1SMN1; SMN2ALDH1A1HRH3KMT2A
SCHEMBL12772770 0.85 GNAI3 (0.38) SMN1; SMN2ALDH1A1TSHRL3MBTL1KMT2A
SCHEMBL8259120 0.83 HPGD (0.49) SMN1; SMN2ALDH1A1L3MBTL1HRH3KMT2A
SCHEMBL13601612 0.82 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1TSHRL3MBTL1HRH3
SCHEMBL12772809 0.81 BDKRB1 (0.37) SMN1; SMN2ALDH1A1TSHRL3MBTL1HRH3
SCHEMBL13608459 0.81 HRH3 (0.42) SMN1; SMN2ALDH1A1HRH3KMT2AHPGD
SCHEMBL13601370 0.81 NAAA (0.50) L3MBTL1HRH3HPGD
SCHEMBL19884745 0.80 NPC1 (0.46) NPC1SMN1; SMN2ALDH1A1L3MBTL1HRH3
SCHEMBL13601633 0.80 NPC1 (0.55) NPC1SMN1; SMN2ALDH1A1TSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed